Imaging predictors of remission to anti-depressant medications in major depressive disorder

Journal of Affective Disorders

Volumn 186, Issue , 2015, Pages 134-144

  Chi, Kee F ^a,b   Korgaonkar, Mayuresh ^b   Grieve, Stuart M ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antidepressant medications; Major depressive disorder; Neuroimaging; Remission

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; BRAIN SIZE; CINGULATE GYRUS; CINGULUM (BRAIN); CORTICAL THICKNESS (BRAIN); DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; META ANALYSIS; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER; ANISOTROPY; BRAIN; DEPRESSIVE DISORDER, MAJOR; ENDOPHENOTYPE; FEMALE; GRAY MATTER; HYPERTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

ANISOTROPY; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DIFFUSION MAGNETIC RESONANCE IMAGING; ENDOPHENOTYPES; FEMALE; GRAY MATTER; HUMANS; HYPERTROPHY; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; REMISSION INDUCTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WHITE MATTER;

EID: 84938271286     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.07.002     Document Type: Review

References (119)

1. G.S. Alexopoulos, D.N. Kiosses, S.J. Choi, C.F. Murphy, and K.O. Lim Frontal white matter microstructure and treatment response of late-life depression: a preliminary study Am. J. Psychiatry 159 2002 1929 1932
2. G.S. Alexopoulos, C.F. Murphy, F.M. Gunning-Dixon, V. Latoussakis, D. Kanellopoulos, S. Klimstra, K.O. Lim, and M.J. Hoptman Microstructural white matter abnormalities and remission of geriatric depression Am. J. Psychiatry 165 2008 238 244
3. G.S. Alves, A.F. Carvalho, F.K. Sudo, V. Oertel-Knochel, C. Knochel, A. de Carvalho Lde, J. Laks, E. Engelhardt, and J. Pantel Structural neuroimaging findings in major depressive disorder throughout aging: a critical systematic review of prospective studies CNS Neurol. Disord. Drug Targets 13 2014 1846 1859
4. D. Arnone, S. McKie, R. Elliott, G. Juhasz, E.J. Thomas, D. Downey, S. Williams, J.F. Deakin, and I.M. Anderson State-dependent changes in hippocampal grey matter in depression Mol. Psychiatry 18 2013 1265 1272
5. D. Arnone, S. McKie, R. Elliott, E.J. Thomas, D. Downey, G. Juhasz, S.R. Williams, J.F. Deakin, and I.M. Anderson Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment Am. J. Psychiatry 169 2012 841 850
6. J. Ashburner, and K.J. Friston Voxel-based morphometry-the methods NeuroImage 11 2000 805 821
7. K. Botteron, C. Carter, F.X. Castellanos, D.P. Dickstein, W. Drevets, K.L. Kim, M.F. Pescosolido, S. Rausch, K.E. Seymour, and Y. Sheline Consensus report of the APA work group on neuroimaging markers of psychiatric disorders 2012 American Psychiatric Association
8. B. Breitenstein, S. Scheuer, and F. Holsboer Are there meaningful biomarkers of treatment response for depression? Drug Discov Today 19 2014 539 561
9. H. Brockmann, A. Zobel, A. Joe, K. Biermann, L. Scheef, A. Schuhmacher, O. von Widdern, M. Metten, H.J. Biersack, W. Maier, and H. Boecker The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression Psychiatry Res. 173 2009 107 112
10. R.L. Buckner, J.R. Andrews-Hanna, and D.L. Schacter The brain's default network: anatomy, function, and relevance to disease Ann. N. Y. Acad. Sci. 1124 2008 1 38
11. E. Bullmore, and O. Sporns Complex brain networks: graph theoretical analysis of structural and functional systems Nat. Rev. Neurosci. 10 2009 186 198
12. F.X. Castellanos, A. Di Martino, R.C. Craddock, A.D. Mehta, and M.P. Milham Clinical applications of the functional connectome NeuroImage 80 2013 527 540
13. Charney, D., Barlow, D., Botteron, K., Cohen, J., 2002. Neuroscience research agenda to guide development of a pathophysiologically based classification system.
14. C.H. Chen, K. Ridler, J. Suckling, S. Williams, C.H. Fu, E. Merlo-Pich, and E. Bullmore Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment Biol. Psychiatry 62 2007 407 414
15. S.G. Costafreda, C. Chu, J. Ashburner, and C.H. Fu Prognostic and diagnostic potential of the structural neuroanatomy of depression PloS one 4 2009 e6353
16. C. Delorenzo, L. Delaparte, B. Thapa-Chhetry, J.M. Miller, J.J. Mann, and R.V. Parsey Prediction of selective serotonin reuptake inhibitor response using diffusion-weighted MRI Front. Psychiatry 4 2013 5
17. W.C. Drevets Orbitofrontal cortex function and structure in depression Ann. N. Y. Acad. Sci. 1121 2007 499 527
18. W.C. Drevets, J.L. Price, and M.L. Furey Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression Brain Struct. Funct. 213 2008 93 118
19. W.C. Drevets, J. Savitz, and M. Trimble The subgenual anterior cingulate cortex in mood disorders CNS Spectrums 13 2008 663 681
20. P.B. Fitzgerald, A.R. Laird, J. Maller, and Z.J. Daskalakis A meta-analytic study of changes in brain activation in depression Hum. Brain Mapp. 29 2008 683 695
21. A. Fornito, and E.T. Bullmore Connectomic intermediate phenotypes for psychiatric disorders Front. Psychiatry 3 2012 32
22. A. Fornito, A. Zalesky, and M. Breakspear Graph analysis of the human connectome: promise, progress, and pitfalls NeuroImage 80 2013 426 444
23. T. Frodl, M. Jager, I. Smajstrlova, C. Born, R. Bottlender, T. Palladino, M. Reiser, H.J. Moller, and E.M. Meisenzahl Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study J. Psychiatry Neurosci. 33 2008 423 430
24. T.S. Frodl, N. Koutsouleris, R. Bottlender, C. Born, M. Jager, I. Scupin, M. Reiser, H.J. Moller, and E.M. Meisenzahl Depression-related variation in brain morphology over 3 years: effects of stress? Arch. Gen. Psychiatry 65 2008 1156 1165
25. C.H. Fu, J. Mourao-Miranda, S.G. Costafreda, A. Khanna, A.F. Marquand, S.C. Williams, and M.J. Brammer Pattern classification of sad facial processing: toward the development of neurobiological markers in depression Biol. Psychiatry 63 2008 656 662
26. C.H. Fu, S.C. Williams, A.J. Cleare, M.J. Brammer, N.D. Walsh, J. Kim, C.M. Andrew, E.M. Pich, P.M. Williams, L.J. Reed, M.T. Mitterschiffthaler, J. Suckling, and E.T. Bullmore Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study Arch. Gen. Psychiatry 61 2004 877 889
27. G. Gartlehner, K. Thaler, S. Hill, and R.A. Hansen How should primary care doctors select which antidepressants to administer? Curr. Psychiatry Rep. 14 2012 360 369
28. I.H. Gotlib, and J.P. Hamilton Neuroimaging and Depression: Current Status and Unresolved Issues Curr. Direct. Psychol. Sci. 17 2008 159 163
29. S.M. Grieve, M.S. Korgaonkar, A. Etkin, A. Harris, S.H. Koslow, S. Wisniewski, A.F. Schatzberg, C.B. Nemeroff, E. Gordon, and L.M. Williams Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial Trials 14 2013 224
30. S.M. Grieve, M.S. Korgaonkar, S.H. Koslow, E. Gordon, and L.M. Williams Widespread reductions in gray matter volume in depression NeuroImage. Clin. 3 2013 332 339
31. F.M. Gunning-Dixon, M. Walton, J. Cheng, J. Acuna, S. Klimstra, M.E. Zimmerman, A.M. Brickman, M.J. Hoptman, R.C. Young, and G.S. Alexopoulos MRI signal hyperintensities and treatment remission of geriatric depression J. Affect. Disord. 126 2010 395 401
32. F.M. Gunning, J. Cheng, C.F. Murphy, D. Kanellopoulos, J. Acuna, M.J. Hoptman, S. Klimstra, S. Morimoto, J. Weinberg, and G.S. Alexopoulos Anterior cingulate cortical volumes and treatment remission of geriatric depression Int. J. Geriatric Psychiatry 24 2009 829 836
33. P. Hagmann, L. Cammoun, X. Gigandet, R. Meuli, C.J. Honey, V.J. Wedeen, and O. Sporns Mapping the structural core of human cerebral cortex PLoS Biol. 6 2008 e159
34. C. Hamani, H. Mayberg, S. Stone, A. Laxton, S. Haber, and A.M. Lozano The subcallosal cingulate gyrus in the context of major depression Biol. Psychiatry 69 2011 301 308
35. J.P. Hamilton, A. Etkin, D.J. Furman, M.G. Lemus, R.F. Johnson, and I.H. Gotlib Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data Am. J. Psychiatry 169 2012 693 703
36. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
37. H. Hanada, J. Imanaga, A. Yoshiiwa, T. Yoshikawa, Y. Tanaka, J. Tsuru, A. Inoue, Y. Ishitobi, S. Okamoto, M. Kanehisa, Y. Maruyama, T. Ninomiya, H. Higuma, K. Isogawa, T. Kawasaki, T. Fujioka, and J. Akiyoshi The value of ethyl cysteinate dimer single photon emission computed tomography in predicting antidepressant treatment response in patients with major depression Int. J. Geriatric Psychiatry 28 2013 756 765
38. R. Hansen, B. Gaynes, P. Thieda, G. Gartlehner, A. Deveaugh-Geiss, E. Krebs, and K. Lohr Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants Psychiatr. Serv. 59 2008 1121 1130
39. A. Heiden, J. Kettenbach, P. Fischer, B. Schein, A. Ba-Ssalamah, R. Frey, M.M. Naderi, T. Gulesserian, D. Schmid, S. Trattnig, H. Imhof, and S. Kasper White matter hyperintensities and chronicity of depression J. Psychiatric Res. 39 2005 285 293
40. A.S. Heller, T. Johnstone, M.J. Peterson, G.G. Kolden, N.H. Kalin, and R.J. Davidson Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months J. Am. Med. Assoc. Psychiatry 70 2013 1181 1189
41. V.A. Holthoff, B. Beuthien-Baumann, G. Zundorf, A. Triemer, S. Ludecke, P. Winiecki, R. Koch, F. Fuchtner, and K. Herholz Changes in brain metabolism associated with remission in unipolar major depression Acta Psychiatr. Scand. 110 2004 184 194
42. P.E. Holtzheimer, M.E. Kelley, R.E. Gross, M.M. Filkowski, S.J. Garlow, A. Barrocas, D. Wint, M.C. Craighead, J. Kozarsky, R. Chismar, J.L. Moreines, K. Mewes, P.R. Posse, D.A. Gutman, and H.S. Mayberg Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression Archiv. Gen. Psychiatry 69 2012 150 158
43. W.S. Hoogenboom, R.H. Perlis, J.W. Smoller, Q. Zeng-Treitler, V.S. Gainer, S.N. Murphy, S.E. Churchill, I.S. Kohane, M.E. Shenton, and D.V. Iosifescu Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry 15 2014 122 134
44. M.H. Hsieh, D.R. McQuoid, R.M. Levy, M.E. Payne, J.R. MacFall, and D.C. Steffens Hippocampal volume and antidepressant response in geriatric depression International journal of geriatric psychiatry 17 2002 519 525
45. T. Insel, B. Cuthbert, and M. Garvey Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders American Journal of 2010 748 751
46. H. Ito, K. Inoue, R. Goto, S. Kinomura, Y. Taki, K. Okada, K. Sato, T. Sato, I. Kanno, and H. Fukuda Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry Annals of nuclear medicine 20 2006 131 138
47. H. Jarnum, S.F. Eskildsen, E.G. Steffensen, S. Lundbye-Christensen, C.W. Simonsen, I.S. Thomsen, E.T. Frund, J. Theberge, and E.M. Larsson Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder Acta psychiatrica Scandinavica 124 2011 435 446
48. A.Y. Joe, T. Tielmann, J. Bucerius, M.J. Reinhardt, H. Palmedo, W. Maier, H.J. Biersack, and A. Zobel Response-dependent differences in regional cerebral blood flow changes with citalopram in treatment of major depression J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 47 2006 1319 1325
49. D.K. Jones, and A. Leemans Diffusion tensor imaging Methods Mol. Biol. 711 2011 127 144
50. J. Jung, J. Kang, E. Won, K. Nam, M.S. Lee, W.S. Tae, and B.J. Ham Impact of lingual gyrus volume on antidepressant response and neurocognitive functions in Major Depressive Disorder: a voxel-based morphometry study J. Affect. Disord. 169 2014 179 187
51. M.J. Kempton, Z. Salvador, M.R. Munafo, J.R. Geddes, A. Simmons, S. Frangou, and S.C. Williams Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder Arch. Gen. Psychiatry 68 2011 675 690
52. M.S. Korgaonkar, N.J. Cooper, L.M. Williams, and S.M. Grieve Mapping inter-regional connectivity of the entire cortex to characterize major depressive disorder: a whole-brain diffusion tensor imaging tractography study Neuroreport 23 2012 566 571
53. M.S. Korgaonkar, A. Fornito, L.M. Williams, and S.M. Grieve Abnormal structural networks characterize major depressive disorder: a connectome analysis Biol. Psychiatry 2014
54. M.S. Korgaonkar, W. Rekshan, E. Gordon, A.J. Rush, L.M. Williams, C. Blasey, and S.M. Grieve Magnetic resonance imaging measures of brain structure to predict antidepressant treatment outcome in major depressive disorder EBioMedicine 2 2015 37 45
55. M.S. Korgaonkar, L.M. Williams, Y.J. Song, T. Usherwood, and S.M. Grieve Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder Br. J. Psychiatry: J. Ment. Sci. 205 2014 321 328
56. A. Kugaya, G. Sanacora, J.K. Staley, R.T. Malison, A. Bozkurt, S. Khan, A. Anand, C.H. Van Dyck, R.M. Baldwin, J.P. Seibyl, D. Charney, and R.B. Innis Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors Biol. Psychiatry 56 2004 497 502
57. C.H. Lai, and Y.T. Wu Duloxetine's modest short-term influences in subcortical structures of first episode drug-naive patients with major depressive disorder and panic disorder Psychiatry Res. 194 2011 157 162
58. R. Lanzenberger, G.S. Kranz, D. Haeusler, E. Akimova, M. Savli, A. Hahn, M. Mitterhauser, C. Spindelegger, C. Philippe, M. Fink, W. Wadsak, G. Karanikas, and S. Kasper Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas NeuroImage 63 2012 874 881
59. C.T. Li, C.P. Lin, K.H. Chou, I.Y. Chen, J.C. Hsieh, C.L. Wu, W.C. Lin, and T.P. Su Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study NeuroImage 50 2010 347 356
60. Y. Liao, X. Huang, Q. Wu, C. Yang, W. Kuang, M. Du, S. Lui, Q. Yue, R.C. Chan, G.J. Kemp, and Q. Gong Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD J. Psychiatry Neurosci. 38 2013 49 56
61. Y.L. Liao, P.S. Wang, C.F. Lu, C.I. Hung, C.T. Li, C.P. Lin, J.C. Hsieh, T.P. Su, and Y.T. Wu Cortical shape and curvedness analysis of structural deficits in remitting and non-remitting depression PloS one 8 2013 e68625
62. N.K. Logothetis, and B.A. Wandell Interpreting the BOLD signal Ann. Rev. Physiol. 66 2004 735 769
63. V. Lorenzetti, N.B. Allen, A. Fornito, and M. Yucel Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies J. Affect. Disord. 117 2009 1 17
64. A.M. Lozano, H.S. Mayberg, P. Giacobbe, C. Hamani, R.C. Craddock, and S.H. Kennedy Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression Biol. Psychiatry 64 2008 461 467
65. G.M. MacQueen, K. Yucel, V.H. Taylor, K. Macdonald, and R. Joffe Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder Biol. Psychiatry 64 2008 880 883
66. H.S. Mayberg Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment Br. Med. Bull. 65 2003 193 207
67. Mayberg, H.S., 2014. Neuroimaging and psychiatry: the long road from bench to bedside. The Hastings Center Report Spec No 2014, S31-S36.
68. H.S. Mayberg, M. Liotti, S.K. Brannan, S. McGinnis, R.K. Mahurin, P.A. Jerabek, J.A. Silva, J.L. Tekell, C.C. Martin, J.L. Lancaster, and P.T. Fox Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness Am. J. Psychiatry 156 1999 675 682
69. H.S. Mayberg, A.M. Lozano, V. Voon, H.E. McNeely, D. Seminowicz, C. Hamani, J.M. Schwalb, and S.H. Kennedy Deep brain stimulation for treatment-resistant depression Neuron 45 2005 651 660
70. C.L. McGrath, M.E. Kelley, B.W. Dunlop, P.E. Holtzheimer 3rd, W.E. Craighead, and H.S. Mayberg Pretreatment brain states identify likely nonresponse to standard treatments for depression Biol. Psychiatry 76 2014 527 535
71. C.L. McGrath, M.E. Kelley, P.E. Holtzheimer, B.W. Dunlop, W.E. Craighead, A.R. Franco, R.C. Craddock, and H.S. Mayberg Toward a neuroimaging treatment selection biomarker for major depressive disorder J. Am. Med. Assoc. Psychiatry 70 2013 821 829
72. M.C. McKinnon, K. Yucel, A. Nazarov, and G.M. MacQueen A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder J. Psychiatry Neurosci. 34 2009 41 54
73. A. Mechelli, C.J. Price, K.J. Friston, and J. Ashburner Voxel-based morphometry of the human brain: methods and applications Curr. Med. Imaging Rev. 1 2005 1 9
74. C.C. Meltzer, J.C. Price, C.A. Mathis, M.A. Butters, S.K. Ziolko, E. Moses-Kolko, S. Mazumdar, B.H. Mulsant, P.R. Houck, B.J. Lopresti, L.A. Weissfeld, and C.F. Reynolds Serotonin 1A receptor binding and treatment response in late-life depression Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 29 2004 2258 2265
75. M.S. Milak, R.V. Parsey, L. Lee, M.A. Oquendo, D.M. Olvet, F. Eipper, K. Malone, and J.J. Mann Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment Psychiatry Res. 173 2009 63 70
76. J.M. Miller, N. Hesselgrave, R.T. Ogden, F. Zanderigo, M.A. Oquendo, J.J. Mann, and R.V. Parsey Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder Biol. Psychiatry 74 2013 760 767
77. J.M. Miller, M.A. Oquendo, R.T. Ogden, J.J. Mann, and R.V. Parsey Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder J. Psychiatr. Res. 42 2008 1137 1144
78. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br. J. Psychiatry: J. Ment. Sci. 134 1979 382 389
79. E.L. Moses-Kolko, J.C. Price, M.E. Thase, C.C. Meltzer, D.J. Kupfer, C.A. Mathis, W.D. Bogers, S.R. Berman, P.R. Houck, T.N. Schneider, and W.C. Drevets Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635 Synapse 61 2007 523 530
80. M.L. Murphy, and T. Frodl Meta-analysis of diffusion tensor imaging studies shows altered fractional anisotropy occurring in distinct brain areas in association with depression Biol. Mood Anxiety Disord. 1 2011 3
81. B. Mwangi, K.P. Ebmeier, K. Matthews, and J.D. Steele Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder Brain: J. Neurol. 135 2012 1508 1521
82. National Institute of Mental Health, 2008. The National Institute of Mental Health Strategic Plan Bethesda MD: National Institute of Mental Health. NIH publication. 08-6368.
83. V. Navarro, C. Gasto, F. Lomena, J.J. Mateos, T. Marcos, and M.J. Portella Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study NeuroImage 16 2002 781 787
84. V. Navarro, C. Gasto, F. Lomena, J.J. Mateos, M.J. Portella, G. Massana, M. Bernardo, and T. Marcos Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: a 12-month follow-up control study J. Clin. Psychiatry 65 2004 656 661
85. V. Navarro, C. Gasto, F. Lomena, X. Torres, J.J. Mateos, M.J. Portella, G. Masana, and T. Marcos Prognostic value of frontal functional neuroimaging in late-onset severe major depression Br. J. Psychiatry: J. Ment. Sci. 184 2004 306 311
86. P. Neu, M. Bajbouj, A. Schilling, F. Godemann, R.M. Berman, and P. Schlattmann Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities J. Psychiatr. Res. 39 2005 129 135
87. G. Northoff, C. Wiebking, T. Feinberg, and J. Panksepp The''resting-state hypothesis' of major depressive disorder-a translational subcortical-cortical framework for a system disorder Neurosci. Biobehav. Rev. 35 2011 1929 1945
88. A. Ogura, S. Morinobu, S. Kawakatsu, S. Totsuka, and A. Komatani Changes in regional brain activity in major depression after successful treatment with antidepressant drugs Acta Psychiatr. Scand. 98 1998 54 59
89. M. Olfson, S.C. Marcus, B. Druss, L. Elinson, T. Tanielian, and H.A. Pincus National trends in the outpatient treatment of depression J.Am. Med. Assoc. 287 2002 203 209
90. G.I. Papakostas, and M. Fava Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 19 2009 34 40
91. R.V. Parsey, D.M. Olvet, M.A. Oquendo, Y.Y. Huang, R.T. Ogden, and J.J. Mann Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 31 2006 1745 1749
92. T.F. Patankar, R. Baldwin, D. Mitra, S. Jeffries, C. Sutcliffe, A. Burns, and A. Jackson Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression J. Affect. Disord. 97 2007 265 270
93. S. Reardon NIH rethinks psychiatry trials Nature 507 2014 288
94. S.R. Ribeiz, F. Duran, M.C. Oliveira, D. Bezerra, C.C. Castro, D.C. Steffens, G. Busatto Filho, and C.M. Bottino Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study PloS one 8 2013 e80049
95. H.G. Ruhe, J. Booij, D.J. Veltman, M.C. Michel, and A.H. Schene Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study J. Clin. Psychiatry 73 2012 451 459
96. A.J. Rush, S.R. Wisniewski, D. Warden, J.F. Luther, L.L. Davis, M. Fava, A.A. Nierenberg, and M.H. Trivedi Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features Arch. Gen. Psychiatry 65 2008 870 880
97. P.G. Samann, D. Hohn, N. Chechko, S. Kloiber, S. Lucae, M. Ising, F. Holsboer, and M. Czisch Prediction of antidepressant treatment response from gray matter volume across diagnostic categories Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 23 2013 1503 1515
98. Y.I. Sheline, D.M. Barch, J.L. Price, M.M. Rundle, S.N. Vaishnavi, A.Z. Snyder, M.A. Mintun, S. Wang, R.S. Coalson, and M.E. Raichle The default mode network and self-referential processes in depression Proc. Natl. Acad. Sci. USA 106 2009 1942 1947
99. Y.I. Sheline, B.M. Disabato, J. Hranilovich, C. Morris, G. D'Angelo, C. Pieper, T. Toffanin, W.D. Taylor, J.R. MacFall, C. Wilkins, D.M. Barch, K.A. Welsh-Bohmer, D.C. Steffens, R.R. Krishnan, and P.M. Doraiswamy Treatment course with antidepressant therapy in late-life depression Am. J. Psychiatry 169 2012 1185 1193
100. Y.I. Sheline, C.F. Pieper, D.M. Barch, K. Welsh-Bohmer, R.C. McKinstry, J.R. MacFall, G. D'Angelo, K.S. Garcia, K. Gersing, C. Wilkins, W. Taylor, D.C. Steffens, R.R. Krishnan, and P.M. Doraiswamy Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial Arch. Gen. Psychiatry 67 2010 277 285
101. D.F. Smith, and S. Jakobsen Molecular neurobiology of depression: PET findings on the elusive correlation with symptom severity Front. Psychiatry 4 2013 8
102. J.R. Sneed, M.E. Culang-Reinlieb, A.M. Brickman, F.M. Gunning-Dixon, L. Johnert, E. Garcon, and S.P. Roose MRI signal hyperintensities and failure to remit following antidepressant treatment J. Affect. Disord. 135 2011 315 320
103. B. Stieltjes, W.E. Kaufmann, P.C. van Zijl, K. Fredericksen, G.D. Pearlson, M. Solaiyappan, and S. Mori Diffusion tensor imaging and axonal tracking in the human brainstem NeuroImage 14 2001 723 735
104. L. Su, Y. Cai, Y. Xu, A. Dutt, S. Shi, and E. Bramon Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies BMC Psychiatry 14 2014 321
105. W.D. Taylor, M. Kuchibhatla, M.E. Payne, J.R. Macfall, Y.I. Sheline, K.R. Krishnan, and P.M. Doraiswamy Frontal white matter anisotropy and antidepressant remission in late-life depression PloS one 3 2008 e3267
106. W.D. Taylor, K. Kudra, Z. Zhao, D.C. Steffens, and J.R. MacFall Cingulum bundle white matter lesions influence antidepressant response in late-life depression: a pilot study J. Affect. Disord. 162 2014 8 11
107. M.E. Thase, B.R. Haight, N. Richard, C.B. Rockett, M. Mitton, J.G. Modell, S. VanMeter, A.E. Harriett, and Y. Wang Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials J. Clin. Psychiatry 66 2005 974 981
108. S. Toki, Y. Okamoto, K. Onoda, T. Matsumoto, S. Yoshimura, Y. Kunisato, G. Okada, K. Shishida, M. Kobayakawa, T. Fukumoto, A. Machino, M. Inagaki, and S. Yamawaki Hippocampal activation during associative encoding of word pairs and its relation to symptomatic improvement in depression: a functional and volumetric MRI study J. Affect. Disord. 152-154 2014 462 467
109. K. Vakili, S.S. Pillay, B. Lafer, M. Fava, P.F. Renshaw, C.M. Bonello-Cintron, and D.A. Yurgelun-Todd Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study Biol. Psychiatry 47 2000 1087 1090
110. M.P. van den Heuvel, and H.E. Hulshoff Pol Exploring the brain network: a review on resting-state fMRI functional connectivity Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 20 2010 519 534
111. T.A. Victor, M.L. Furey, S.J. Fromm, A. Ohman, and W.C. Drevets Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder Arch. Gen. Psychiatry 67 2010 1128 1138
112. G. Wagner, K. Koch, C. Schachtzabel, T. Sobanski, J.R. Reichenbach, H. Sauer, and R.G. Schlosser Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression J. Psychiatry Neurosci. 35 2010 247 257
113. N.D. Walsh, S.C. Williams, M.J. Brammer, E.T. Bullmore, J. Kim, J. Suckling, M.T. Mitterschiffthaler, A.J. Cleare, E.M. Pich, M.A. Mehta, and C.H. Fu A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy Biol. Psychiatry 62 2007 1236 1243
114. M. Walter, and A. Lord How can we predict treatment outcome for depression? EBioMedicine 2 2015 9 10
115. L. Wang, K. Li, Q. Zhang, Y. Zeng, W. Dai, Y. Su, G. Wang, Y. Tan, Z. Jin, X. Yu, and T. Si Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging Psychol. Med. 44 2014 1417 1426
116. Y. Wang, Y. Fan, P. Bhatt, and C. Davatzikos High-dimensional pattern regression using machine learning: from medical images to continuous clinical variables NeuroImage 50 2010 1519 1535
117. L.M. Williams, A.J. Rush, S.H. Koslow, S.R. Wisniewski, N.J. Cooper, C.B. Nemeroff, A.F. Schatzberg, and E. Gordon International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol Trials 12 2011 4
118. M. Wu, C. Rosano, M. Butters, E. Whyte, M. Nable, R. Crooks, C.C. Meltzer, C.F. Reynolds 3rd, and H.J. Aizenstein A fully automated method for quantifying and localizing white matter hyperintensities on MR images Psychiatry Res. 148 2006 133 142
119. A. Zalesky, A. Fornito, and E.T. Bullmore Network-based statistic: identifying differences in brain networks NeuroImage 53 2010 1197 1207